Stockscreener 앱 받기
1.1814
0.72%
-0.0086
전일 마감가:
$1.19
열려 있는:
$1.21
하루 거래량:
44,769
Relative Volume:
0.07
시가총액:
$29.80M
수익:
-
순이익/손실:
$-10.21M
주가수익비율:
-2.0223
EPS:
-0.5842
순현금흐름:
-
1주 성능:
+0.97%
1개월 성능:
-3.16%
6개월 성능:
+11.45%
1년 성능:
+4.55%
1일 변동 폭
$1.18
$1.23
1주일 범위
$1.12
$1.27
52주 변동 폭
$0.80
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
NRSN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.1814 | 29.80M | 0 | -10.21M | 0 | -0.5842 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.20 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.85 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.46 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.21 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Neurosense Therapeutics Ltd 주식(NRSN)의 최신 뉴스
Historical volatility pattern of NeuroSense Therapeutics Ltd. Equity Warrant visualized2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Evaluating NeuroSense Therapeutics Ltd. with trendline analysis2025 Analyst Calls & Safe Entry Point Identification - newser.com
Smart tools for monitoring NeuroSense Therapeutics Ltd.’s price actionJuly 2025 Patterns & Daily Profit Maximizing Tips - newser.com
How NeuroSense Therapeutics Ltd. Equity Warrant stock performs in stagflationDividend Hike & Proven Capital Preservation Tips - newser.com
What institutional flow reveals about NeuroSense Therapeutics Ltd.2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Is it too late to sell NeuroSense Therapeutics Ltd.July 2025 Opening Moves & Reliable Price Action Trade Plans - newser.com
What momentum indicators show for NeuroSense Therapeutics Ltd. stockTrade Analysis Summary & Real-Time Market Sentiment Alerts - newser.com
Using R and stats models for NeuroSense Therapeutics Ltd. Equity Warrant forecasting2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
Is NeuroSense Therapeutics Ltd. stock poised for growth2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com
Volume spikes in NeuroSense Therapeutics Ltd. stock – what they meanTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
Can a trend reversal in NeuroSense Therapeutics Ltd. lead to recoveryTrade Exit Report & Weekly Stock Breakout Alerts - newser.com
How sentiment analysis helps forecast NeuroSense Therapeutics Ltd. Equity WarrantSwing Trade & Reliable Intraday Trade Plans - newser.com
Will NeuroSense Therapeutics Ltd. stock return to pre crisis levelsJuly 2025 Volume & Daily Stock Trend Watchlist - newser.com
Using economic indicators to assess NeuroSense Therapeutics Ltd. Equity Warrant potentialWeekly Trade Review & Daily Chart Pattern Signal Reports - newser.com
Using data filters to optimize entry into NeuroSense Therapeutics Ltd.Weekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Can NeuroSense Therapeutics Ltd. Equity Warrant rally from current levelsTrade Analysis Summary & Safe Entry Point Identification - newser.com
Real time scanner hits for NeuroSense Therapeutics Ltd. explained2025 Risk Factors & Long-Term Safe Investment Plans - newser.com
Will NeuroSense Therapeutics Ltd. (H1Z) stock draw ESG focused fundsInsider Selling & Free Daily Entry Point Trade Alerts - newser.com
Backtesting results for NeuroSense Therapeutics Ltd. trading strategiesTrade Signal Summary & AI Forecasted Entry/Exit Points - newser.com
NeuroSense Therapeutics Ltd. stock momentum explainedInsider Selling & Stock Portfolio Risk Management - newser.com
NeuroSense Therapeutics (NASDAQ:NRSN) Shares Down 1.7% – Time to Sell? - Defense World
NeuroSense: PrimeC Produces Statistically Significant Reductions in Alzheimer's Disease Biomarkers - Sahm
Why NeuroSense Therapeutics Ltd. (H1Z) stock attracts wealthy investorsJuly 2025 Volume & Consistent Growth Equity Picks - newser.com
NeuroSense Announces Promising Alzheimer’s Biomarker Reductions with PrimeC - TipRanks
Neurosense Therapeutics LtdPrimeC produces statistically significant reductions in Alzheimer's disease biomarkers - MarketScreener
Heatmap analysis for NeuroSense Therapeutics Ltd. Equity Warrant and competitorsPrice Action & Daily Oversold Stock Bounce Ideas - newser.com
Will NeuroSense Therapeutics Ltd. stock continue dividend increasesJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - newser.com
Why NeuroSense Therapeutics Ltd. stock is rated strong buyMarket Activity Report & Daily Profit Focused Screening - newser.com
Is NeuroSense Therapeutics Ltd. (H1Z) stock undervalued after correctionInsider Selling & High Win Rate Trade Tips - newser.com
Published on: 2025-10-05 05:10:08 - newser.com
Will NeuroSense Therapeutics Ltd. Equity Warrant stock maintain dividend yieldJuly 2025 Review & Daily Chart Pattern Signals - newser.com
Leading vs lagging indicators on NeuroSense Therapeutics Ltd. Equity Warrant performanceEarnings Risk Report & High Yield Stock Recommendations - newser.com
Published on: 2025-10-05 02:56:57 - newser.com
NeuroSense Reports Positive Initial Results for Alzheimer’s Drug Candidate - MSN
Why hedge funds are buying NeuroSense Therapeutics Ltd. Equity Warrant stock2025 Historical Comparison & Momentum Based Trading Signals - newser.com
Is NeuroSense Therapeutics Ltd. Equity Warrant stock undervalued vs historical averagesTrade Analysis Summary & Safe Capital Growth Tips - newser.com
Published on: 2025-10-03 05:13:43 - newser.com
Why NeuroSense Therapeutics Ltd. (H1Z) stock is a must watch tickerJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
Neurosense Therapeutics Ltd (NRSN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.09%
자본화:
|
볼륨(24시간):